causal

Biology AI creates software value unlike old biotech

Models can let AI-native software capture enormous value in biology, different from the traditional biotech model of making drugs and taking biobucks deals, and this changes the capital structure and distribution of outcomes for companies serving pharma.

causalpending

Speaker

Sarah Guo

Evidence Quote

“The conventional wisdom ... was the only way you make money in biotech or serving pharma is by making a drug and then get biobucks deals”

Source

Sarah Guo - Funding the Frontier - [Invest Like the Best, EP.489]— Invest Like the Best
Created: 11/17/2026, 6:50:18 AM

Your notes

Loading notes...